Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Owen M. Rennert is active.

Publication


Featured researches published by Owen M. Rennert.


Pharmacology, Biochemistry and Behavior | 1984

Systematic comparison of apomorphine-induced behavioral changes in two mouse strains with inherited differences in brain dopamine receptors

Thomas W. Seale; Kim McLanahan; Pamela Johnson; John M. Carney; Owen M. Rennert

Dosage and time dependencies of apomorphine-induced changes in stereotyped behaviors (climbing, gnawing and sniffing), locomotor activity and rearing activity were compared in young adult male mice of two inbred strains, DBA/2 and C57BL/6. These two strains are known to differ in their genetically specified brain dopamine receptor number. Apomorphine administered intraperitoneally at dosages of 0.5-20 mg/kg failed to induced stereotyped climbing in DBA/2 at any of the doses tested but markedly increased climbing in C57BL/6 at higher dosages. Apomorphine-induced stereotyped gnawing occurred in both strains at higher dosages although the latency was shorter and maximal effect greater in C57BL/6. Stereotyped sniffing was induced in both strains to a comparable degree at doses greater than or equal to 2.0 mg/kg, and the duration of this stereotypy was indistinguishable between strains. Locomotor activity was inhibited maximally in DBA/2 at an apomorphine dosage of 2 mg/kg and was inhibited to a greater extent than was C57BL/6. Rearing was inhibited in both strains by doses of apomorphine greater than or equal to 0.5 mg/kg; however the duration of the effect was considerably greater in DBA/2 than in C57BL/6. These data suggest that genetically determined differences in central dopamine receptors may have profound and selective effects on behaviors mediated by dopamine pathways; that complex behavioral patterns, e.g., apomorphine-induced stereotypy, may be dissected in to individual components by identifying neuropharmaco genetic differences between strains; that marked strain-specific, inherited differences in dopamine agonist-induced behavioral changes do occur among inbred, non-mutant mouse strains and that their occurrence in other mammalian species including man should be considered.


Pharmacology, Biochemistry and Behavior | 1987

Coincidence of seizure susceptibility to caffeine and to the benzodiazepine inverse agonist, DMCM, in SWR and CBA inbred mice

Thomas W. Seale; John M. Carney; Owen M. Rennert; Marinus Flux; Phil Skolnick

Several lines of evidence suggest that the convulsant actions of caffeine are mediated through benzodiazepine receptors. A pharmacogenetic approach has been used to further explore the relationship of these receptors to caffeine-induced seizures. The susceptibility of two inbred strains of mice (CBA and SWR) to the convulsant actions of picrotoxinin, strychnine, Ro 5-4864 and DMCM was examined. Previous studies have demonstrated these two strains differ in their susceptibilities to the convulsant action of caffeine. While no differences were observed between these two strains in susceptibility to tonic seizures induced by picrotoxinin, RO 5-4864 or strychnine, SWR mice were significantly less sensitive to tonic seizures induced by DMCM compared to CBA mice (CD50 values in CBA and SWR mice were 6 and 12 mg/kg IP). Both clonazepam and the benzodiazepine receptor antagonist, Ro 15-1788, significantly blocked caffeine-induced seizures. Further, when subconvulsant doses of caffeine and DMCM were combined, a synergistic action was observed. Taken together, these findings support the hypothesis that the convulsant actions of caffeine result from an action at benzodiazepine receptors, and that the hyporesponsiveness of the SWR strain to both caffeine- and DMCM-induced seizures could result from an inherited abnormality in these sites.


The Journal of Pediatrics | 1978

Familial ichthyosis, dwarfism, mental retardation, and renal disease

Abigail Rayner; Richard P. Lampert; Owen M. Rennert

The nonrandom association of congenital ichthyosis with neurologic impairment, ectodermal dysplasia, dwarfism, hypogonadism, and renal disease has prompted the review of numerous syndromes. The difficulties in characterization of syndromes in the absence of pathognomonic signs is discussed in relation to three siblings presented herein. Despite extensive investigation, underlying metabolic defects remain obscure.


Pharmacology, Biochemistry and Behavior | 1985

Inheritance of amphetamine-induced thermoregulatory responses in inbred mice

Thomas W. Seale; John M. Carney; Pamela Johnson; Owen M. Rennert

Two inbred strains of mice, DBA/2 and C57BL/6, differ in their responses to d-amphetamine-induced alteration of core temperature. At low doses of amphetamine (e.g., 2 mg/kg IP), both strains become markedly hypothermic within 10-20 minutes. High doses (e.g., 20 mg/kg IP) induce significant hyperthermia (+1.8 degrees C) in DBA/2 mice but have only a slight hyperthermic effect (+0.2-0.3 degrees C) effect on C57BL/6 mice. The phenotype of the F1 hybrid strain derived by crossing C57BL/6 by DBA/2 is indistinguishable from its C57BL/6 parent at a dose of 20 mg/kg IP, i.e., reduced responsiveness to amphetamine-induced hyperthermia is dominant. Analysis of the thermoregulatory responses of recombinant inbred derivatives (lines BXD-9, 11, 15, 19, 20, 21, 23, 27, 28, 30) suggest that the relative responses to amphetamine-induced hyperthermia is inherited in a simple Mendelian fashion. These results differ from other pairs of inbred mouse strains which have been compared. These findings identify yet another neuropharmacological difference between mouse strains C57BL/6 and DBA/2 and are reviewed in terms of neuroregulatory mechanisms effecting thermoregulation.


Archives of Biochemistry and Biophysics | 1979

A polyamine-conjugated peptide isolated from human plasma.

Thomas W. Seale; Wai-Yee Chan; Jayesh Shulka; Owen M. Rennert

Abstract When human plasma was fractionated by gel exclusion chromatography on Bio-Gel P-10, substantial quantities of putrescine and trace amounts of spermidine were consistently associated with a 4200 M r peptide species. Putrescine was not removed from the peptide by extensive dialysis, desalting, multiple gel and ion exchange chromatographic procedures, nor by incubation with urea followed by trichloroacetic acid precipitation. No putrescine was detected unless the peptide was acid hydrolyzed. Incubation of plasma with 14 C-labeled putrescine did not result in association of the label with the peptide. We conclude that these polyamines appear to be covalently bound to this major plasma peptide species. The amount of putrescine associated with the peptide is 10- to 40-fold the concentration of unbound plasma putrescine per equivalent amount of plasma. The peptide was purified to apparent homogeneity and was found to be a single chain composed of 32 amino acid residues with a combined molecular weight of 4180. Possible biological roles of this polyamine conjugated peptide are discussed.


Clinica Chimica Acta | 1979

Isolation and characterization of a polyamine-peptide conjugate from human amniotic fluid.

Thomas W. Seale; Wai-Yee Chan; J.B. Shukla; Owen M. Rennert

Significant amounts of the diamine putrescine and the polyamines spermidine and spermine could be detected in human third-trimester amniotic fluid only after acid hydrolysis. This observation was interpreted to mean that these amines existed only in conjugated form in this biological fluid. Upon fractionation by ultrafiltration 90--10% of the putrescine was associated with the 1000--10 000 dalton fraction. Spermine was identified in this fraction and in a low-molecular weight fraction presumably representing acetylated derivatives. Spermidine was entirely associated with the 10 000--30 000 dalton fraction. The putrescine conjugate was purified to homogeneity by column chromatography on Biogels P10 and P6 followed by ion-exchange chromatography on DEAE-Sephadex A-25. Molecular weight by gel exclusion using peptide standards was estimated to be approx. 4600. The UV absorption spectrum of the putrescine conjugate conformed to that expected for a polypeptide. This putrescine conjugate contained 39 identified amino acids with a combined molecular weight of 4713. Putrescine was detectable by high pressure liquid chromatography only after acid hydrolysis of the conjugate. No other polyamines were detected in these hydrolyzates, nor were any polyamines demonstable in hydrolyzates of control peptides nor in pooled column washes. The identity of the putrescine determined by high pressure liquid chromatography was confirmed by a two-dimensional thin-layer chromatography method. These results establish the in vivo production of a putrescine--polypeptide conjugate in man. Such molecular species may constitute yet another metabolic pathway for polyamines or may reflect another mode of post-translational modification of polypeptide structure and function. The qualitative and quantitative analysis of polyamine conjugate in human aminotic fluid may prove to be useful in the detection of abnormalities in fetal development.


Critical Reviews in Clinical Laboratory Sciences | 1981

Polyamines as tumor markers.

James R. Shipe; John Savory; Michael R. Wills; Owen M. Rennert

(1981). Polyamines as Tumor Markers. CRC Critical Reviews in Clinical Laboratory Sciences: Vol. 16, No. 1, pp. 1-34.


Life Sciences | 1986

Androgen receptors in ventral prostate glands of zinc deficient rats

Kyung Won Chung; Sook Young Kim; Wai-Yee Chan; Owen M. Rennert

Androgen binding has been studied in the prostate cytosol of zinc deficient rats by charcoal assays. Rats were housed individually in plastic cages and maintained on a zinc deficient diet for 3 months. The cytosol fraction of prostate gland was incubated with various concentrations of tritiated methyltrienolone (3H-R1881, a synthetic androgen) alone or in the presence of 500-fold excess of radioinert R1881. Scatchard analysis of the data revealed that the number of androgen binding sites in the cytosol fraction of the zinc deficient rat prostate was 31 +/- 5.2 fmol/mg cytosol protein. This was significantly lower than that (84 +/- 11.5 fmol/mg protein) of the controls. Their dissociation constant (Kd = 1.6 +/- 0.6 nM) on the other hand was not different from that (1.7 +/- 0.7 nM) of control animals. This decrease in the concentration of cytosol receptor sites in the zinc deficient state suggests that this metal is involved in the androgen-binding process in the target cells.


Pharmacology, Biochemistry and Behavior | 1985

A single gene difference determines relative susceptibility to caffeine-induced lethality in SWR and CBA inbred mice

Thomas W. Seale; Pamela Johnson; Thomas H. Roderick; John M. Carney; Owen M. Rennert

Inbred mouse strains SWR and CBA differ markedly in their relatively susceptibility to the acute toxic effects of intraperitoneally administered caffeine. At a dose of 187 mg/kg, SWR mice survive a stress-potentiated lethality test apparently related to the generation of tonic seizures; in contrast, CBA mice usually die in less than 30 seconds after this dose. Progeny from several different genetic crosses were characterized to determine the genetic basis underlying this phenotypic difference in caffeine sensitivity. F1 progeny from reciprocal crosses of the parental strains were uniformly sensitive to caffeine-induced lethality, i.e., caffeine responsiveness behaves like an autosomal dominant trait. Self-crossing of F1 individuals produced both progeny which were resistant to caffeine-induced lethality (26% of the total) and those which were susceptible (74%). Backcrosses of the F1 animals to the CBA parent produced no (0/19) resistant progeny. In contrast, backcrosses of F1 animals to SWR produced 54% resistant progeny. These data indicate that the difference in susceptibility to caffeine-induced lethality between these strains is determined by a single pair of autosomal alleles in which susceptibility (responsiveness) to this methylxanthine is dominant to resistance (nonresponsiveness).


Pharmacology, Biochemistry and Behavior | 1986

Complex genetic determinants of susceptibility to methylxanthine-induced locomotor activity changes.

Thomas W. Seale; Thomas H. Roderick; Pamela Johnson; Lance Logan; Owen M. Rennert; John M. Carney

The intent of this study was to investigate the role of inheritance in the determination of susceptibility to methylxanthine-induced behavioral changes. Two strains of inbred mice, SWR and CBA, which differ significantly in their response to caffeine- and theophylline-induced stimulation of locomotor activity, were used in classical genetic crosses to produce reciprocal F1 hybrids, reciprocal backcross progeny F2 progeny. Theophylline dose response curves in the reciprocal F1 hybrid strains were identical to each other and to their methylxanthine-responsive (CBA) parent. These results indicated that theophylline responsiveness behaved as a simple autosomal dominant trait. Behavioral responses of these F1 hybrid strains to caffeine showed the same maximal enhancement of locomotor activity as their CBA progenitor at a dose 10 mg/kg IP, but locomotor activity stimulation also occurred at 32 mg/kg IP, a dose which inhibited their CBA parent. These data suggest that the genes specifying caffeine responsiveness differ from those encoding theophylline responsiveness. For both caffeine and theophylline, behavioral phenotypes and their expected frequencies of occurrence among backcross and F2 progeny differed significantly from the segregation ratios expected for a trait determined by a single gene. These non-Mendelian segregation ratios suggest that locomotor activity stimulation by both of these methylxanthines is polygenically determined. It was anticipated that the same genetically encoded neurochemical mechanism would underlie the difference in behavioral response to the two methylxanthines. However, no significant correlation between caffeine-induced and theophylline-induced stimulation of locomotor activity was observed among progeny derived from backcrosses of F1 self-crosses.(ABSTRACT TRUNCATED AT 250 WORDS)

Collaboration


Dive into the Owen M. Rennert's collaboration.

Top Co-Authors

Avatar

Wai-Yee Chan

University of Oklahoma Health Sciences Center

View shared research outputs
Top Co-Authors

Avatar

Thomas W. Seale

University of Oklahoma Health Sciences Center

View shared research outputs
Top Co-Authors

Avatar

John M. Carney

University of Oklahoma Health Sciences Center

View shared research outputs
Top Co-Authors

Avatar

Kyung Won Chung

University of Oklahoma Health Sciences Center

View shared research outputs
Top Co-Authors

Avatar

James M. Bates

University of Oklahoma Health Sciences Center

View shared research outputs
Top Co-Authors

Avatar

Pamela Johnson

University of Oklahoma Health Sciences Center

View shared research outputs
Top Co-Authors

Avatar

Guy E. Griesmann

University of Oklahoma Health Sciences Center

View shared research outputs
Top Co-Authors

Avatar

M. Hassan Raghib

University of Oklahoma Health Sciences Center

View shared research outputs
Top Co-Authors

Avatar

Jeannie R. Himes

University of Oklahoma Health Sciences Center

View shared research outputs
Top Co-Authors

Avatar

Jim Bates

University of Oklahoma Health Sciences Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge